Predictmedix Inc
CNSX:PMED
Predictmedix Inc
Predictmedix, Inc. operates as an artificial intelligence company. The company is headquartered in Toronto, Ontario. The company went IPO on 2019-12-20. The firm's business is focused on developing artificial intelligence (AI) powered technologies for general workplace health and safety, and for the health care industry. Its primary product, Infectious Disease Symptom Screening Solutions (IDSS), identifies and detects infectious disease symptoms, including COVID-19, its variants, and other infectious diseases. Its IDSS is marketed in North America under the name Safe Entry System. In addition, the Company is developing AI powered products, such as Impairment Detection Screening, which detects alcohol and/or cannabis impairment in individuals; Mental Health Screening, which detects behavioral and physiological indicators of mental illness such as depression, autism, attention deficit hyperactivity disorder (ADHD) and dementia, and remote patient monitoring and treatment plans, which is referred as the Mobile Wellbeing product.
Predictmedix, Inc. operates as an artificial intelligence company. The company is headquartered in Toronto, Ontario. The company went IPO on 2019-12-20. The firm's business is focused on developing artificial intelligence (AI) powered technologies for general workplace health and safety, and for the health care industry. Its primary product, Infectious Disease Symptom Screening Solutions (IDSS), identifies and detects infectious disease symptoms, including COVID-19, its variants, and other infectious diseases. Its IDSS is marketed in North America under the name Safe Entry System. In addition, the Company is developing AI powered products, such as Impairment Detection Screening, which detects alcohol and/or cannabis impairment in individuals; Mental Health Screening, which detects behavioral and physiological indicators of mental illness such as depression, autism, attention deficit hyperactivity disorder (ADHD) and dementia, and remote patient monitoring and treatment plans, which is referred as the Mobile Wellbeing product.
